Targeting Poly(ADP-Ribose) Polymerase and the c-Myb–Regulated DNA Damage Response Pathway in Castration-Resistant Prostate Cancer
Likun Li(The University of Texas MD Anderson Cancer Center), Timothy C. Thompson(The University of Texas MD Anderson Cancer Center), Ana M. Aparicio(The University of Texas MD Anderson Cancer Center), Nora M. Navone(The University of Texas MD Anderson Cancer Center), Patricia Troncoso(The University of Texas MD Anderson Cancer Center), Jianhua Yin(BGI Group (China)), Theodoros Karantanos(Johns Hopkins University), Masato Dobashi(The University of Texas MD Anderson Cancer Center), Paul G. Corn(Cornell University), Ju‐Seog Lee(The University of Texas MD Anderson Cancer Center), Lianchun Xiao(The University of Texas MD Anderson Cancer Center), Takahiro Hirayama(National Defense Medical College), Wenjun Chang(Second Military Medical University), Guang Yang(Jinan University), Hyun‐Sung Lee(Baylor College of Medicine), Eleni Efstathiou(The University of Texas MD Anderson Cancer Center), Sankar N. Maity(The University of Texas MD Anderson Cancer Center), Jianxiang Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Wenling Zhang(Central South University), Styliani Karanika(Johns Hopkins University), Sanghee Park(The University of Texas MD Anderson Cancer Center), Elsa M. Li Ning Tapia(The University of Texas MD Anderson Cancer Center), Bradley M. Broom(The University of Texas MD Anderson Cancer Center), Chengzhen Ren(The University of Texas MD Anderson Cancer Center), Parantu K. Shah(Ono Pharmaceutical (United States))
Cited by 87
Related Papers
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
The Molecular Taxonomy of Primary Prostate Cancer
|Cell|2015|3.3k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k